comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 19:25:09 - browse：374

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Covid’s new normal has set in amid another rise in cases

entertainment

leisure time

WSS

Canadians with cystic fibrosis outlive Americans by a decade

Covid’s new normal has set in amid another rise in cases

PBMs drew scrutiny in House hearing — and so did pharma

'A game

PBMs drew scrutiny in House hearing — and so did pharma

Use doctors trained outside the U.S. to ease the physician shortage

focus

comprehensive

explore

In age of alternative facts, a scholarly course on calling out crap

Why the drug industry's warnings on the IRA's impact fall short

Medical records are filled with copy

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Duchenne breakthrough therapy leaves behind pioneering families

Assistant physicians can help address the primary care shortage

Duchenne breakthrough therapy leaves behind pioneering families

Information blocking fines are now fair game in health care

United colonoscopy coverage change 'may cost lives,' doctors say

Security flaws in third

focus

Fed up with FDA, ALS advocates consider a take

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Assistant physicians can help address the primary care shortage

UpToDate has a racism problem: Dr. Stanley Goldfarb

Vertex cell therapy lets patients with type 1 diabetes stop insulin

focus

entertainment

leisure time

focus